Results 1 to 10 of about 2,590,210 (272)

Impact of postoperative infection on changes in leucocyte levels in early postoperative period in patients undergoing splenectomy during cytoreductive surgery for gynaecological malignancy [PDF]

BMC Cancer
Background In cytoreductive surgery for gynecological cancers, 13-25% of patients require splenectomy. Therefore, hematological parameters change in the post-splenectomy period, especially leucocytosis and thrombocytosis.
Yeşim Özkaya Uçar, Tufan Arslanca, Okan Aytekin, Gülşah Tiryaki Güner, Serpil Ünlü, Günsu Kimyon Cömert, Fatih Kılıç, Aziz Ahmet Sürel, Taner Turan   +8 more
doaj   +4 more sources

Primary cytoreductive surgery or interval cytoreductive surgery

Taiwanese Journal of Obstetrics & Gynecology
Yiu-Tai Li, Szu-Ting Yang, Peng-Hui Wang
doaj   +4 more sources

Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study

World Journal of Surgical Oncology, 2022
Background Cytoreductive surgery followed by systemic chemotherapy is the standard of treatment in advanced ovarian cancer where feasible. Neoadjuvant chemotherapy (NACT) followed by surgery is applicable where upfront cytoreductive surgery is not ...
Ester Miralpeix, Josep-Maria Sole-Sedeno, Cristina Rodriguez-Cosmen, Alvaro Taus, Maria-Dolors Muns, Berta Fabregó, Gemma Mancebo   +6 more
doaj   +2 more sources

The efficacy of cytoreductive surgery for oligometastatic prostate cancer: a meta-analysis

World Journal of Surgical Oncology, 2021
Backgrounds At present, the application of tumor reduction surgery in oligometastatic prostate cancer has aroused extensive discussion among urologists, but clinicians have not reached a consensus on this issue.
Bisheng Cheng, Shuchao Ye, Peiming Bai
doaj   +2 more sources

Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Metastatic Endometrial Cancer. [PDF]

Cancer Med
ABSTRACT Objective To evaluate the pattern of use and clinical outcomes associated with neoadjuvant chemotherapy (NACT) compared with primary debulking surgery (PDS) in patients with stage IV endometrial cancer. Methods We utilized the National Cancer Database to identify individuals diagnosed with stage IV endometrial cancer, and categorized them ...
Sassine D, Huang Y, Hur C, Elkin EB, Ferris JS, Melamed A, Kong CY, Myers ER, Bickell NA, Hazelton WD, Layne TM, Heckman-Stoddard B, Samimi G, Havrilesky LJ, Blank SV, Xu X, Wright JD.   +16 more
europepmc   +2 more sources

Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures [PDF]

JAMA Network Open, 2019
Key Points Question What are the morbidity and mortality of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) compared with other major oncologic surgical procedures?
Jason M. Foster, Richard Sleightholm, Asish Patel, Valerie Shostrom, Bradley R. Hall, Beth K. Neilsen, David L. Bartlett, Lynette M. Smith   +7 more
openalex   +2 more sources

The current role of secondary cytoreductive surgery for recurrent ovarian cancer

Frontiers in Oncology, 2022
Ovarian cancer represents worldwide the second most frequent and the most fatal gynecological malignancy, with approximately two thirds of the patients presenting with advanced disease. Cytoreductive surgery, primary or after neoadjuvant chemotherapy, in
Eelco de Bree, Dimosthenis Michelakis, Elisavet Anagnostopoulou   +2 more
doaj   +2 more sources

Robotic-Assisted Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy in Metastatic Pleuropulmonary Leiomyosarcoma: A Case Report. [PDF]

Case Rep Oncol Med
Leiomyosarcoma (LMS) is a rare and aggressive soft tissue sarcoma known for its propensity for hematogenous dissemination, frequently involving the lungs and pleura. We present a case of metastatic pleuropulmonary LMS managed with a novel combined approach: robotic‐assisted cytoreductive surgery and hyperthermic intrathoracic chemotherapy (HITHOC).
de Oliveira MC, D'Ambrosio PD, Cunha DP, Marotta RC, Said MM, Mingarini Terra R.   +5 more
europepmc   +2 more sources

Prognostic Factors and Nomogram-Based Prediction Models for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis Undergoing Cytoreductive Surgery: A Retrospective Cohort Study. [PDF]

Cancer Med
ABSTRACT Background Colorectal cancer (CRC) with synchronous peritoneal metastasis (SPM) presents poor prognosis and complex treatment challenges. This study aimed to identify independent prognostic factors and develop nomogram‐based prediction models for overall survival (OS) and progression‐free survival (PFS) in CRC patients with SPM (CRC‐SPM ...
Ge X, Yang G, Wu H, Liu L, Zhou M, Zhu A, Kong X, Wu J, Hu Y, Ding K, Sun L, Wang J.   +11 more
europepmc   +2 more sources

Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial

Journal of Clinical Oncology, 2023
PURPOSE In patients with peritoneal metastasis (PM) from gastric cancer (GC), chemotherapy is the treatment of choice. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are still being debated. This randomized, controlled,
B. Rau, Hauke Lang, Alfred Koenigsrainer, Ines Gockel, H. Rau, Hendrik Seeliger, Christian Lerchenmueller, D. Reim, Roger Wahba, Martin Angele, S. Heeg, Tobias Keck, Arved Weimann, Stefan Topp, P. Piso, A. Brandl, Silke Schuele, Peter Jo, J. Pratschke, Sandra Wegel, A. Rehders, N. Moosmann, J. Gaedcke, Volker Heinemann, E. Trips, Markus Loeffler, P. Schlag, P. Thuss-Patience   +27 more
semanticscholar   +1 more source